Clinical Trial Update: Effectiveness of Urinary Alkalinizing Agents on Kidney Stone Risk [Phase 4]

View source ↗

Summary

Phase 4 trial updating on the effectiveness of urinary alkalinizing agents in reducing kidney stone risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Stone

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Kidney Stone | Phase 4 | Status: COMPLETED